# US 2019/0166827 A1 · Cryopreservation of cartilage and osteochondral tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0166827 A1
- Document ID: US20190166827A1
- Status: Published application
- Kind: A1
- Application number: 16/249,689
- Filed: 2019-01-16
- Published: 2019-06-06
- Earliest claimed: 2015-08-07
- Assignees: AlloSource
- Applicants: AlloSource
- Inventors: Carolyn Barrett Rorick
- Web page: https://patentgrep.com/patent/US20190166827A1

## CPC

- A01N 1/16: Physical preservation processes
- A01N 1/125: Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- A01N 1/142: Apparatus
- A01N 1/162: Temperature processes, e.g. following predefined temperature changes over time
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS

## Abstract

Provided are systems and methods for cryopreserving tissue, particularly cartilage tissue and osteochondral tissue. Also provided are tissue products made using such systems and methods. Certain methods involve combining tissue with a cryopreservation solution in a processing vessel and applying resonant acoustic energy thereto prior to freezing the tissue. The resonant acoustic energy rapidly agitates the tissue with the cryopreservation solution by vibration. By applying resonant acoustic energy to the tissue during processing, the rate or efficiency of processing, or both, may be improved. Certain methods involve soaking tissue in a cryopreservation solution prior to freezing the tissue.

## Claims

### Claim 1

A method of cryopreserving tissue, the method comprising:
(a) loading a processing vessel with a tissue and a cryopreservation solution, thereby providing a combination comprising the tissue and the cryopreservation solution disposed in the processing vessel, wherein the tissue is cartilage tissue or osteochondral tissue;
(b) applying resonant acoustic energy to the processing vessel, thereby vibrating the processing vessel and the combination disposed therein to form a processed tissue comprising the tissue mixed with the cryoprotectant; and
(c) freezing the processed tissue to form a cryopreserved tissue.

### Claim 2 (depends on 1)

The method of claim 1, wherein the cryopreservation solution comprises a buffer or culture medium containing a cryoprotectant agent.

### Claim 3 (depends on 2)

The method of claim 2, wherein the cryoprotectant agent is at least one of dimethyl sulfoxide (DMSO), methanol, butanediol, propanediol, polyvinylpyrrolidone, glycerol, hydroxyethyl starch, alginate, or a glycol.

### Claim 4 (depends on 2)

The method of claim 2, wherein the cryoprotectant agent is DMSO.

### Claim 5 (depends on 2)

The method of claim 2, wherein the cryopreservation solution comprises 10% to 20% (vol/vol) of the cryoprotectant agent.

### Claim 6 (depends on 1)

The method of claim 1, wherein the processed tissue is removed from the processing vessel and soaked in a second cryopreservation solution for up to 2 hours prior to freezing, or wherein the tissue is soaked in a second cryopreservation solution for up to 2 hours prior to being placed in the processing vessel.

### Claim 7 (depends on 1)

The method of claim 1, wherein resonant acoustic energy is applied for 10 to 60 minutes.

### Claim 8 (depends on 1)

The method of claim 1, wherein the resonant acoustic energy exerts 10 to 60 times the energy of G-force (10-60 G) on the processing vessel and combination therein.

### Claim 9 (depends on 1)

The method of claim 1, wherein the resonant acoustic energy has a frequency of 15 Hertz to 60 Hertz.

### Claim 10 (depends on 1)

The method of claim 1, wherein the tissue, the processing solution, or both, are evaluated after application of the resonant acoustic energy to assess at least one characteristic.

### Claim 11 (depends on 1)

The method of claim 1, wherein the tissue is frozen to a temperature of −80° C.

### Claim 12 (depends on 1)

The method of claim 1, wherein the tissue is frozen in a solution comprising serum and 10-20% cryoprotectant agent.

### Claim 13 (depends on 12)

The method of claim 12, wherein the cryoprotectant agent is DMSO.

### Claim 14 (depends on 1)

A cryopreserved tissue product made according to the method of claim 1.

### Claim 15 (depends on 14)

The cryopreserved tissue product of claim 14, wherein the cryopreserved tissue product retains at least 70% cell viability after two years in storage upon being thawed.

### Claim 16 (depends on 14)

The cryopreserved tissue product of claim 14, wherein the cryopreserved tissue product retains at least 80% cell viability after two years in storage at −80° C. upon being thawed.

### Claim 17 (depends on 14)

The cryopreserved tissue product of claim 14, wherein the cryopreserved tissue product retains at least 90% cell viability after two years in storage at −80° C. upon being thawed.

### Claim 18

A method of cryopreserving a tissue, the method comprising soaking the tissue in a cryopreservation solution for up to 2 hours and then placing the tissue at freezing temperatures, thereby producing a cryopreserved tissue, wherein the tissue is cartilage tissue or osteochondral tissue.

### Claim 19 (depends on 18)

A cryopreserved tissue product made according to the method of claim 18.
